S

+ Studies in 2000-2009 List
* Studies in Pre-2000 List

SAFETY AS A MEDICINE*+
SAFETY-ADULTERANTS/CONTAMINANTS*+
SCHISTOSOMA INFECTION +
SCHIZOPHRENIA/MENTAL DISORDERS*+
SCLERODERMA +
SEBACEOUS GLANDS + (Produce Skin Oils)
SEPTIC SHOCK/SEPSIS*+
SHINGLES
SICKLE CELL DISEASE +
SINUSITIS (See 2000-2009 List)
SLEEP APNEA +
SLEEPING SICKNESS/TRYPANOSOMIASIS* (See Also CHAGAS DISEASE)
SLEEP MODULATION*+
SMALLPOX + (See Also COW POX [not good news])
SMELL/ODOR DETECTION +
SMOKED CANNABIS AS A MEDICATION*+ (See Also METHODS OF USE-SMOKING)
SOCIAL ADJUSTMENT/BEHAVIOR*+
SPASTICITY*+
SPINAL CORD INJURY*+
SPINOCEREBELLAR ATAXIA/SCA (Inherited Neurodegenerative Disorder. See Also ATAXIA)
SPLEEN*+
SPORTS (see Also EXERCISE)
STEM CELLS +
STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE +
STRESS + (See Also ANXIETY, POST TRAUMATIC STRESS DISORDER)
STORAGE of CANNABIS*+
STROKE*+ (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY)
STUTTERING +
SUICIDE +


SAFETY AS A MEDICINE
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full-2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Drug Harms in the UK (full-2010) http://www.scribd.com/doc/41349905/Alcohol-Lancet-2010
Harms associated with psychoactive substances: findings of the UK National Drug Survey (abst-2010) http://jop.sagepub.com/cgi/content/abstract/24/2/147?rss=1
Alcohol ‘Most Harmful Drug’, According to Multicriteria Analysis (news-2010) http://www.sciencedaily.com/releases/2010/11/101101162138.htm
top
A summary of the health harms of drugs – Section 5 Cannabis (full-2011) http://www.nta.nhs.uk/uploads/healthharmsfinal-v1.pdf
Annual Causes of Death in the United States (article-2011) http://drugwarfacts.org/cms/?q=node/30
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/22129319/abstract/Safety_and_Side_Effects_of_Cannabidiol_a_Cannabis_sativa_Constituent_
Oregon’s workplaces safest ever, despite 40,000 medical marijuana patients (news-2011) http://www.examiner.com/article/oregon-s-workplaces-safest-ever-despite-40-000-medical-marijuana-patients
Is Pot Good For You? (news-2011) http://www.maps.org/media/view/is_pot_good_for_you/
Prescribing Cannabis for Harm Reduction (full-2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
Medical Marijuana: Clearing Away the Smoke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716148
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Synthetic cannabinoid and marijuana exposures reported to poison centers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22859662
Study on Non-Psychotropic Cannabinoid Proves to be Safe in Humans (news-2012) http://www.opposingviews.com/i/society/drug-law/study-non-psychotropic-cannabinoid-proven-be-safe-humans
Is Medical Marijuana Safe for Children? (news-2012) http://healthland.time.com/2012/11/28/is-medical-marijuana-safe-for-children/
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
The pharmacologic and clinical effects of medical cannabis (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (abst + 1st page-2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Physical harm due to chronic substance use. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23542091
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24084047
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24160757
Medical marijuana users don’t have protections from sub-par pot (news-2013) http://www.katu.com/news/investigators/Medical-marijuana-users-dont-have-protections-from-sub-par-pot-200499471.html
Is Medical Marijuana Safe For Children and Adolescents? (news-2013) http://www.wakingtimes.com/2013/05/27/is-medical-marijuana-safe-for-children-and-adolescents/
No detectable association between frequency of marijuana use and health or healthcare utilization (news-2013) http://www.eurekalert.org/pub_releases/2013-09/bumc-nda092313.php
top
Marijuana has no adverse effects on health, BU study suggests (news-2013) http://dailyfreepress.com/2013/09/25/marijuana-has-no-adverse-effects-on-health-bu-study-suggests/
Study: Recreational Marijuana Users Show No ‘Negative Health Outcomes’ (news-2013) http://www.leafscience.com/2013/09/24/study-recreational-marijuana-users-show-negative-health-outcomes/
No detectable association between frequency of marijuana use and health or healthcare utilization (news-2013) http://medicalxpress.com/news/2013-09-association-frequency-marijuana-health-healthcare.html
Alcohol or Cannabis? No Question Which Substance Poses a Greater Risk to Health (news-2013) http://www.huffingtonpost.com/paul-armentano/alcohol-or-cannabis_b_3799972.html
How Much Marijuana Does It Take For Someone To Overdose? (news-2013) http://www.theweedblog.com/how-much-marijuana-does-it-take-for-someone-to-overdose/
Phytocannabinoids and epilepsy (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full-2014) http://www.cfp.ca/content/60/12/1083.long
A new method of cannabis ingestion: The dangers of dabs? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24930049
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst-2014)
http://www.ncbi.nlm.nih.gov/pubmed/24943098
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25035121
Re-branding cannabis: the next generation of chronic pain medicine? (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Scientists Explain Why Marijuana Users Never Overdose (news-2014) http://www.leafscience.com/2014/01/08/scientists-explain-marijuana-users-never-overdose/
Which is more dangerous: marijuana or alcohol? (news-2014) http://www.abc15.com/dpp/news/local_news/water_cooler/which-is-more-dangerous-marijuana-or-alcohol Poll: 47% in under-40 crowd say booze worse than weed (news-2014) http://www.kirotv.com/news/news/rare-under-40-poll-whats-worse-marijuana-or-alcoho/nhP3y/
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25634572
The cannabis conundrum: Thinking outside the THC box (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/jcph.511/full
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic
Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/nl9g6x6
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product—Colorado, March 2014 (full-2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter-2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
top
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (abst-2015)
http://www.ncbi.nlm.nih.gov/pubmed/25759401
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012 (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25646638
Responsible and controlled use: Older cannabis users and harm reduction (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25911027
A safer alternative: Cannabis substitution as harm reduction (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
European rating of drug harms (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25922421
Marijuana’s Risky Reputation Is Wafting Away (news-2015) http://www.livescience.com/50003-marijuana-risk-perception.html
Why Is Marijuana A Schedule I Drug? (news-2015) http://www.ibtimes.com/why-marijuana-schedule-i-drug-1821426
Colorado’s legal pot is potent, and a little dirty (news-2015) http://www.newschannel10.com/story/28588200/colorados-legal-pot-is-potent-and-a-little-dirty
UCLA Professor Finds Marijuana Is Safer to Smoke Than Tobacco (news-2015) http://www.laweekly.com/music/ucla-professor-finds-marijuana-is-safer-to-smoke-than-tobacco-5658317
The laws on alcohol and marijuana are totally out of sync with the science (news-2015) http://finance.yahoo.com/news/study-confirms-laws-alcohol-marijuana-201029468.html;_ylt=AwrSyCQFpO9UUUMADLjQtDMD
Medical marijuana users could help researchers define risks, benefits (news-2015) https://ca.news.yahoo.com/medical-marijuana-users-could-help-090000965.html
Ladies, you might want to swap the bourbon for a bong (news-2015) http://www.theguardian.com/commentisfree/2015/apr/27/ladies-you-might-want-to-swap-the-bourbon-fora-bong
6 facts about marijuana (news-2015) http://www.pewresearch.org/fact-tank/2015/04/14/6-facts-about-marijuana/
Huge New Review Shows What Medical Marijuana May (and May Not) Help (news-2015) https://www.yahoo.com/health/huge-new-review-shows-what-medical-marijuana-may-122209836947.html
Study confirms safety of cannabis drug CBD (news-2015) https://www.epilepsy.org.uk/news/news/study-confirms-safety-cannabis-drug-cbd-64709
What is the scope of marijuana use in the United States? (news-2015) http://www.drugabuse.gov/publications/research-reports/marijuana/what-scope-marijuana-use-in-unitedstates
The Science Of Decriminalizing Drugs (news-2015) http://www.popsci.com/science-decriminalize-legalize-drugs-marijuana-weed
How the media used one tiny study to wildly exaggerate the threat of marijuana edibles (news-2015) http://www.vox.com/2015/6/22/8826011/pot-edibles-dangerous


SAFETY-ADULTERANTS/CONTAMINANTS
CUT, A Guide to the Adulterants, Bulking agents and other Contaminants found in illicit drugs (full-2010) http://www.cph.org.uk/publication/cut-a-guide-to-the-adulterants-bulking-agents-and-other-contaminants-found-in-illicit-drugs/
Contamination – Now we have some real evidence (news–2010) http://ukcia.org/wordpress/?p=296
Medical marijuana tested for toxins and impurities (news-2010) http://www.wmbfnews.com/Global/story.asp?S=12340335
Too many mouldy joints – marijuana and chronic pulmonary aspergillosis (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/?tool=pubmed
top
Fatal alveolar haemorrhage following a “bang” of cannabis (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21943539
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348083/
Can medical marijuana help rheumatoid arthritis? (news-2012) http://healthyliving.msn.com/diseases/rheumatoid-arthritis/can-medical-marijuana-help-rheumatoid-arthritis-1
Determination of pesticide residues in cannabis smoke (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666265/
Hemoptysis in a young man smoking cannabis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23619207
Medical marijuana users don’t have protections from sub-par pot (news-2013) http://www.katu.com/news/investigators/Medical-marijuana-users-dont-have-protections-from-sub-par-pot-200499471.html
Moldy Marijuana? Legal Markets Spark Push for Health, Safety Standards (news-2013) http://www.cnbc.com/id/100678723
Legalized marijuana states draft laws on purity of pot (news-2013) http://www.dailycamera.com/state-west-news/ci_23690495/legalized-marijuana-states-draft-laws-purity-pot?source=rss
Marijuana Pesticide Contamination Becomes Health Concern As Legalization Spreads (news-2013) http://www.huffingtonpost.com/2013/05/24/marijuana-pesticides-contamination_n_3328122.html
Recurrent myopericarditis as a complication of Marijuana use (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097/
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24859075
Inhaled medicinal cannabis and the immunocompromised patient (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25413634
Testing of Colorado marijuana for contaminants to begin this year (news-2014) http://gazette.com/testing-of-pot-for-contaminants-to-begin-this-year/article/1536213
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst-2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
Colorado’s legal pot is potent, and a little dirty (news-2015) http://www.newschannel10.com/story/28588200/colorados-legal-pot-is-potent-and-a-little-dirty
Marijuana Legalization 2015: EPA Issues Guidance On Marijuana Pesticides Amid Industry Uncertainty (news-2015) http://www.ibtimes.com/marijuana-legalization-2015-epa-issues-guidance-marijuana-pesticides-amidindustry-1959030
Marijuana’s Pesticide Problem (news-2015) http://finance.yahoo.com/news/marijuanas-pesticide-problem-160701940.html;_ylt=AwrXnCduW4JVqwsABr_QtDMD;_ylu=X3oDMTByb2lvbXVuBGNvbG8DZ3ExBHBvcwMxBHZ0aWQDBHNlYwNzcg–


SCHISTOSOMA INFECTION 
Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23663762
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
top


SCHIZOPHRENIA/MENTAL DISORDERS
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Reasons for illicit drug use in people with schizophrenia: Qualitative study (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999587/?tool=pubmed
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed
Therapeutical use of the cannabinoids in psychiatry (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
Tardive Dystonia and the Use of Cannabis (letter/ forum repost-2010) http://www.420magazine.com/forums/dystonia/169902-tardive-dystonia-use-cannabis.html
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/19785914/abstract/A_behavioural_comparison_of_acute_and_chronic_Delta9_tetrahydrocannabinol_and_cannabidiol_in_C57BL/6JArc_mice_
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19854030
Brain cannabinoid CB2 receptor in schizophrenia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931854
Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study (abst–2010)http://www.ncbi.nlm.nih.gov/pubmed?term=20851843
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20660494
Attraction to cannabis among men with schizophrenia: a phenomenological study (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20420097
Alterations in Metabotropic Glutamate Receptor 1a and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia (news – 2010) http://ajp.psychiatryonline.org/article.aspx?articleID=102528&resultClick=1
Oral THC Reduces Aggressive Behavior In Patients With Refractory Psychosis, Study Says (news – 2010) http://www.norml.org/index.cfm?Group_ID=8419
Risk of suicide spurs rimonabant trial to end (news-2010) http://www.thefreelibrary.com/Risk+of+suicide+spurs+rimonabant+trial+to+end.-a0238838571
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full–2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html
top
Cannabis use predicts shorter duration of untreated psychosis and lower levels of negative symptoms in first-episode psychosis: a South African study (full-2011) http://www.ajop.co.za/Journals/November2010/Original%20articles/Cannabis%20use.pdf
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full-2011) http://www.hindawi.com/journals/sprt/2011/501726/
Gadolinium-HU-308-incorporated micelles (full – 2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full-2011) http://jop.sagepub.com/content/26/1/144.long
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis, COMT and psychotic experiences (full – 2011) http://bjp.rcpsych.org/content/199/5/380.long
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives (full – 2011) http://jop.sagepub.com/content/26/1/150.full.pdf+html
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full – 2011) http://www.schres-journal.com/article/S0920-9964%2811%2900224-6/fulltext
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21458498
Synthetic cannabinoid JWH-018 and psychosis: An explorative study (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21316162/abstract/Synthetic_cannabinoid_JWH_018_and_psychosis:_An_explorative_study_
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21278728
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts – 2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21087649
Endocannabinoid system dysfunction in mood and related disorders (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21916860
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21798112
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
top
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/20701826/abstract/The_schizophrenia_susceptibility_gene_neuregulin_1_modulates_tolerance_to_the_effects_of_cannabinoids_
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannabinoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_event_related_P300_potential_
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21430651
Marijuana Use Associated With ‘Superior’ Cognitive Performance In Schizophrenic Patients, Study Says (news-2011) http://www.norml.org/index.cfm?Group_ID=8537
A Brain Wrought Without Omega-3 (news – 2011) http://www.schizophreniaforum.org/new/detail.asp?id=1646
Debunking the Myth of a Link Between Marijuana and Mental Illness (news-2011) http://www.alternet.org/drugs/151776
COMT; another “wrong” result for the reefer madness hype (news-2011) http://ukcia.org/wordpress/?p=924
Synthetic cannabis linked to extended psychosis (news-2011) http://medicalxpress.com/news/2011-05-synthetic-cannabis-linked-psychosis.html
The Link Between Marijuana and Schizophrenia (news – 2011) http://www.time.com/time/health/article/0,8599,2005559,00.html
Why Omega-3s Affect Your Mood (news – 2011) http://voices.yahoo.com/why-omega-3s-affect-mood-8180941.html?cat=5
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong (full-2012) http://easap.asia/journal_file/1201_V22N1_p31.pdf
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full-2012) http://www.biomedcentral.com/1471-244X/12/112
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full-2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
top
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1425/full
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cortical basket cell dysfunction in schizophrenia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full-2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF-2012) http://www.eurekaselect.com/102848/article
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst-2012) http://www.sciencedirect.com/science/article/pii/S0920996412001740
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22687521
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716160
Neurocognitive functioning and cannabis use in schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Anandamide dysfunction in prodromal and established psychosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst-2012) http://www.springerlink.com/content/ur5784gm34782505/
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
‘Cannabis’ receptor discovery may help understanding of obesity and pain (news-2012) http://phys.org/news/2012-08-cannabis-receptor-discovery-obesity-pain.html
top
Study: Marijuana Linked to Lower Mortality Rate for Patients with Psychotic Disorders (news-2012) http://www.alternet.org/newsandviews/article/936220/study%3A_marijuana_linked_to_lower_mortality_rate_for_patients_with_psychotic_disorders/
Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news-2012) http://www.mhhub.com/archives/16603
Marijuana Compound May Beat Antipsychotics at Treating Schizophrenia (news-2012) http://psychcentral.com/news/2012/06/07/marijuana-compound-may-beat-antipsychotics-at-treating-schizophrenia/39803.html
Marijuana Use Linked to Better Adherence in Psychosis (news-2012) http://www.clinicalpsychiatrynews.com/index.php?id=2407&cHash=071010&tx_ttnews%5Btt_news%5D=138709
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
Cannabis and psychosis: what causes what? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (full – 2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/acps.12108/full
“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report (full – 2013) http://onlinelibrary.wiley.com/doi/10.1002/hup.2312/full
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
What does a mouse tell us about neuregulin 1-cannabis interactions? (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013) http://link.springer.com/article/10.1007/s00213-012-2839-1
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608
top
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21640/abstract
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Peripheral endocannabinoid system dysregulation in first-episode psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23822951
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
The role of cannabinoid 1 receptor expressing interneurons in behavior (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabidiol as a potential treatment for psychosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
High K2 use rate among psych unit patients (news – 2013) http://www.odt.co.nz/news/national/262756/high-k2-use-rate-among-psych-unit-patients
GABA deficits disturb endocannabinoid system (news – 2013) http://www.sciencecodex.com/read/gaba_deficits_disturb_endocannabinoid_system-84784
Cannabis psychosis admissions rose after drug reclassified to Class B (news–2013) http://www.guardian.co.uk/science/sifting-the-evidence/2013/jul/18/cannabis-psychosis-uk-drug-class-c
Harvard: Marijuana Doesn’t Cause Schizophrenia (news-2013) http://psychcentral.com/news/2013/12/10/harvard-marijuana-doesnt-cause-schizophrenia/63148.html
Can The Cannabis Component Cannabidiol (CBD) Cure Schizophrenia? (news-2013) http://www.examiner.com/article/can-the-cannabis-component-cannabidiol-cbd-cure-schizophrenia?cid=PROD-redesign-right-next
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full-2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full-2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
top
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full – 2014) http://jpn.ca/wp-content/uploads/2014/12/39-6-140081.pdf
Cannabinoids and schizophrenia: therapeutic prospects (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
A controlled family study of cannabis users with and without psychosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24309013
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24418217
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24457285
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic predisposition to schizophrenia associated with increased use of cannabis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24957864
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25176118
Cannabis use and suicidal ideations in high-school students (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25253856
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522381
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25539511
top
The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce anti-psychotic effects (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.13000/abstract
Is Medical Marijuana Destined to Become a Top Schizophrenia Treatment? (news – 2014) (requires free registration) http://www.fool.com/investing/general/2014/09/13/is-medical-marijuana-destined-to-become-a-topschi.aspx
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page-2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite_Related.14.aspx
Cannabis conundrum : Evidence of harm? : Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article-2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25618402
Marijuana Could Be the Answer to Fighting These 3 Diseases (news-2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Impact of Cannabis Use on the Development of Psychotic Disorders (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Synthetic cannabis-induced mania (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Cannabis and psychopathology: The meandering journey of the last decade (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page-2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite
_Related.14.aspx
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25363799
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25680767
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25716487
top
A systematic review of the antipsychotic properties of cannabidiol in humans (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25667194
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst-2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25801289
ssociation of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26071625
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26093170
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Catatonia and Cannabis Withdrawal: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247767
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
Marijuana Could Be the Answer to Fighting These 3 Diseases (news–2015) (may require free registration) http://www.fool.com/investing/general/2015/01/10/marijuana-could-be-the-answer-to-fighting-these-3.aspx
Schizophrenia and weight gain: A new explanation? (news–2015) http://www.alphagalileo.org/ViewItem.aspx?ItemId=149445&CultureCode=en
Cannabinoids may be responsible for weight gain associated with schizophrenia (news–2015) http://medicalxpress.com/news/2015-02-cannabinoids-responsible-weight-gain-schizophrenia.html
Study finds no link between teen marijuana use, mental health issues (news–2015) http://www.foxnews.com/health/2015/08/04/study-finds-no-link-between-teen-marijuana-use-mentalhealth-issues/
Teen marijuana use not linked to later depression, lung cancer, other health problems, study finds (news–2015) http://www.sciencedaily.com/releases/2015/08/150804093718.htm


SCLERODERMA 
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21177293
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22492781
top
Pathogenesis of Systemic Sclerosis (full-2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full


SEBACEOUS GLANDS 
“Sebocytes’ makeup”: novel mechanisms and concepts in the physiology of the human sebaceous glands (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21384129
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24915599
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full-2014) http://www.jci.org/articles/view/64628


SEPTIC SHOCK/SEPSIS
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
The endocannabinoid system in sepsis – a potential target to improve microcirculation? (full-2011) http://www.signavitae.com/articles/review-articles/161-the-endocannabinoid-system-in-sepsis-a-potential-target-to-improve-microcirculation
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21279327
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full-2012) http://ccforum.com/content/16/2/R47
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full-2012) http://journals.lww.com/anesthesia
analgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures.12.aspx
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full – 2013) http://www.hindawi.com/journals/mi/2013/741303/
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/review-articles/222-targeting-the-endocannabinoid-system-to-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full-2014) http://www.hindawi.com/journals/mi/2014/978678/
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Novel approaches to the development of anti-sepsis drugs (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24697209
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
top
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full-2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long


SHINGLES
Cannabis Salve for Pain- Neuropathy – Yep, I had shingles 😦 (news-2015) http://www.hempista.com/2015/cannabis-salve-pain-neuropathy-shingles/


SICKLE CELL DISEASE 
New Era Dawns on Sickle Cell Pain (full–2010) http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
Pain related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids (full-2010) http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Cannibinoids Offer Novel Treatment for Pain in Sickle Cell Disease, Study Suggests (news-2010) http://www.sciencedaily.com/releases/2010/07/100722121225.htm
UM researcher identifies novel treatment for pain in sickle cell disease (news–2010) http://www.eurekalert.org/pub_releases/2010-07/uom-uri072210.php
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
Priapism in a patient with sickle cell trait using marijuana (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24798364
Minnesota’s New Medical Marijuana Law Blocks Research Treating Chronic Sickle Cell Pain (news-2014) http://www.huffingtonpost.com/2014/06/11/minnesota-medical-marijuana_n_5485383.html
Medical marijuana could treat pain caused by sickle cell disease (news-2014) http://www.mndaily.com/news/campus/2014/06/10/medical-marijuana-could-treat-pain-caused-sickle-cell-disease
Vaporized medical marijuana study given green light (news-2014) http://abc7news.com/health/vaporized-medical-marijuana-study-given-green-light/261437/
The Miracle Worker (news-2014) http://ireadculture.com/article-3695-the-father-of-modern-medical-cannabis-research-returns-with-an-allbut-impossible-new-study-of-cannabis-on-humans.html
The Science Behind Sanjay Gupta’s WEED 3 (news-2015) http://blog.sfgate.com/smellthetruth/2015/04/21/the-science-behind-sanjay-guptas-weed-3/


SLEEP APNEA 
Circulating endocannainoids and N-acyl-ethanolamides in patients with sleep apnea – specific role of oleoylethanolamide (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20429051
A study on the endogenous cannabinoid system synthetic and catabolic enzyme levels in patients with obstructive sleep apnea (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21729625
Treat sleep apnea with medical marijuana (news – 2011) http://www.examiner.com/holistic-health-in-boulder/treat-sleep-apnea-with-medical-marajuana
top
Circulating anandamide and blood pressure in patients with obstructive sleep apnea (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23032139
Can cannabinoid drug used for nausea in chemotherapy relieve sleep apnea? (news – 2012) http://medicalxpress.com/news/2012-06-cannabinoid-drug-nausea-chemotherapy-relieve.html
Proof of concept trial of dronabinol in obstructive sleep apnea (full-2013) http://www.frontiersin.org/Sleep_Disorders/10.3389/fpsyt.2013.00001/full
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24121138
Science/Human: THC reduces sleep apnoea in small clinical study (news-2013) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=392
5 Ways Marijuana Affects Your Sleep (news-2013) http://www.leafscience.com/2013/11/25/5-ways-marijuana-affects-sleep/
Identification of a Pharmacological Target for Genioglossus Reactivation throughout Sleep (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902869/
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0111412
Cannabinoid Type 1 Receptor Antagonist, AM251, Prevents Attenuation Of Serotonininduced Apneas By Dronabinol In Sprague-Dawley Rats (abst-2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3901


SLEEPING SICKNESS/TRYPANOSOMIASIS
Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full-2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10


SLEEP MODULATION
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/?tool=pubmed
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial (full-2010) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2010/02000/The_Effects_of_Nabilone_on_Sleep_in_Fibromyalgia_.56.aspx
Sleep and Medicinal Cannabis (abst–2010) http://www.cmcr.ucsd.edu/index.php?option=com_content&view=article&id=151:sleep-and-medicinal-cannabis&catid=41:research-studies&Itemid=135
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574
top
Dreams, endocannabinoids and itinerant dynamics in neural networks: re elaborating Crick-Mitchison unlearning hypothesis (abst–2010) http://adsabs.harvard.edu/abs/2002cond.mat..8590K
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20056119
Study: Smoking pot may ease chronic pain (news – 2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136458/?tool=pubmed
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats (full–2011) http://www.hindawi.com/journals/sd/2011/178469/
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/22/9/2086.long
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21262236
Medical marijuana turns former soldier’s life around (news-2011) http://www.examiner.com/cannabis-culture-in-phoenix/medical-marijuana-turns-former-soldier-s-life-around
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder (full-2012) http://www.cadth.ca/media/pdf/htis/july-2012/RC0368%20Cannabinoids%20Final.pdf
Cannabidiol in humans-the quest for therapeutic targets (full – 2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Oleamide restores sleep in adult rats that were subjected to maternal separation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22975223
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst – 2012) http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&resourcetype=HWCIT
Neuromodulators for pain management in rheumatoid arthritis (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Marijuana Helps Ease MS Symptoms, Study Finds (news – 2012) http://www.healthline.com/health-blogs/study-roundup/marijuana-multiple-sclerosis-101112
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23343597
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23584096
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking CB1 cannabinoid receptors (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/926.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
top
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23238438
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23721537
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23952899
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343597
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24412475
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt (abst–2013) http://www.sciencedirect.com/science/article/pii/S030646031300172X
Federal Government Reports Marijuana Effective in Combatting Certain Cancers Reports ADSI (news–2013) http://www.reuters.com/article/2013/03/12/idUSnGNXUXIPEa+1fe+GNW20130312
Medical marijuana helps senior sleep, contend with other problems of aging (news–2013) http://www.ottawacitizen.com/health/seniors/Medical+marijuana+helps+senior+sleep+contend+with+other/8439474/story.html
Poor Sleep Quality Makes It Harder To Quit Marijuana – Here’s Why (news-2013) http://www.leafscience.com/2013/09/27/poor-sleep-quality-makes-harder-quit-marijuana-why/
Medical Marajuana: Consortium of Multiple Sclerosis Centers (news-2013) http://www.msviews.org/msviewsandnews4/index.php/2012-05-28-00-15-54/2012-07-04-00-19-28/610-medical-marajuana-consortium-of-multiple-sclerosis-centers
Too little sleep may trigger the ‘munchies’ by raising levels of an appetite-controlling molecule (news-2013) http://www.sciencecodex.com/too_little_sleep_may_trigger_the_munchies_by_raising_levels_of_an_appetitecontrolling_molecule-114190
5 Ways Marijuana Affects Your Sleep (news – 2013) http://www.leafscience.com/2013/11/25/5-ways-marijuana-affects-sleep/
Smoking Pot Eases Tremors in Parkinson’s (news – 2013) http://www.medpagetoday.com/MeetingCoverage/MDS/39933
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors. (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Therapeutic benefits of cannabis: a patient survey (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508153
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24800644
top
Potential effects of cannabidiol as a wake-promoting agent (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24851090
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24987795
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
When time stands still: an integrative review on the role of chronodisruption in posttraumatic stress disorder. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25023884
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25356522
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25467221
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25467221
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full-2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
The effects of chronic marijuana use on circadian entrainment. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25801606
Cannabis withdrawal and sleep: A systematic review of human studies. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25893849
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Rhythmic control of endocannabinoids in the rat pineal gland. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26061461
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst-2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
top
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Rhythmic control of endocannabinoids in the rat pineal gland (abst-2015) http://informahealthcare.com/doi/abs/10.3109/07420528.2015.1041596
Marijuana use ups daytime sleepiness among kids (news–2015) http://www.newkerala.com/news/2015/fullnews-19303.html
Can Medical Marijuana Treat Multiple Sclerosis? (news–2015) http://www.webmd.com/multiple-sclerosis/features/medical-marijuana-multiplesclerosis?src=RSS_PUBLIC


SMALLPOX 
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
Genome-wide association study of antibody response to smallpox vaccine (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367131/
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full-2015) http://www.hindawi.com/journals/mi/2015/349176/


SMELL/ODOR DETECTION 
The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis (full–2010) http://www.jneurosci.org/content/30/26/8965.long
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20875432
Endocannabinoid modulation in the olfactory epithelium (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20865377
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/early/2011/02/11/annonc.mdq727.full
Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA Release (full–2011) http://www.hindawi.com/journals/ijcb/2011/529851/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Drug Raids Based on “Smelling” Marijuana (news-2011) http://www.opposingviews.com/i/society/crime/drug-raids-based-smelling-marijuana
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb. (full– 2012) http://www.jneurosci.org/content/32/25/8475.long
G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134
In 1981 STASH cologne for men attracted women as well as police and their dogs (news – 2013) http://www.anorak.co.uk/369898/strange-but-true/in-1981-stash-cologne-for-men-attracted-women-as-well-as-police-and-their-dogs.html/
The Truth About Marijuana Smoke: A Smelly Study (news/ad–2013) http://www.airfilters.com/blog/the-truth-about-marijuana-smoke-a-smelly-study/
top
Identification of odorant-receptor interactions by global mapping of the human odorome (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093037
Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System (link to PDF–2014) http://www.mdpi.com/1424-8220/14/7/13256
The endocannabinoid system controls food intake via olfactory processes (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24802974
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25261796
Mechanism elucidated: How smell perception influences food intake (news–2014) http://www.sciencedaily.com/releases/2014/02/140210114550.htm
The brain mechanism connecting the sense of smell with appetite is discovered (news–2014) http://www.alphagalileo.org/ViewItem.aspx?ItemId=138885&CultureCode=en
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26037800
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
Well, can you still smell that smell? (news–2015) http://www.aspendailynews.com/section/home/167350
Ruling: Smell of marijuana can’t be only basis for searches (news–2015) http://www.tucsonnewsnow.com/story/29609893/ruling-smell-of-marijuana-cant-be-only-basis-forsearches


SMOKED CANNABIS AS A MEDICATION
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma (article – 2010) http://www.canadianjournalofophthalmology.ca/article/S0008-4182%2810%2980129-2/abstract
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=316
Cannabis Inhalation Associated With Spontaneous Tumor Regression (news – 2010) http://blog.norml.org/2011/03/22/cannabis-inhalation-associated-with-spontaneous-tumor-regression-study-says/
Study: Smoking pot may ease chronic pain (news – 2010) http://www.cnn.com/2010/HEALTH/08/30/health.pot.reduce.pain/
Smoking cannabis relieves chronic pain (news – 2010) http://www.independent.co.uk/life-style/health-and-families/smoking-cannabis-relieves-chronic-pain-2067287.html
Smoked cannabis reduces chronic pain (news – 2010) http://phys.org/news202360294.html
top
Marijuana better than pharmaceuticals at treating chronic pain, improving mood (news – 2010)  ttp://www.naturalnews.com/029662_marijuana_chronic_pain.html
Marijuana Smoking Associated with 66% Decrease in Diabetes Risk (news – 2010) http://www.internalmedicinenews.com/index.php?id=495&cHash=071010&tx_ttnews[tt_news]=18557
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation (full – 2011) http://cannabisclinicians.org/wp-content/uploads/2011/12/Cannabis-Inhalation-and-Brain-Tumor-Regression-2011.pdf
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Inhaled Cannabis May Keep Brain Cancer in Remission (news – 2011) http://www.freedomisgreen.com/inhaled-marijuana-may-keep-brain-cancer-in-remission/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full – 2012) http://www.cmaj.ca/content/184/10/1143.long
Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia. (full – 2012) http://onlinelibrary.wiley.com/doi/10.1002/acr.21732/full
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23159379
Use of cannabis among 139 cluster headache sufferers (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23197349
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http://health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiple-sclerosis.aspx
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults (full – 2013) http://www.amjmed.com/article/S0002-9343%2813%2900200-3/fulltext
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis (full – 2013) http://cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Cannabis and other illicit drug use in epilepsy patients (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/ene.12081/full
Towards a better Cannabis drug. (full – 2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005175.pub3/full
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full – 2013) http://www.jleukbio.org/content/92/5/1093.full
Medical Marijuana Coverage Still Lost in the Legal Weeds (article – 2013) http://www.managedcaremag.com/linkout/2013/1/23
Medicinal Cannabis and Painful Sensory Neuropathy (editorial – 2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23609132
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23648372
top
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Study claims marijuana tied to lower bladder cancer risk (news – 2013) http://www.usatoday.com/story/news/nation/2013/05/11/study-claims-marijuana-tied-to-lower-bladder-cancer-risk/2153019/
Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection (news – 2013) http://www.aidsmap.com/Smoking-cannabis-does-not-accelerate-progression-of-liver-disease-in-people-with-HIVHCV-co-infection/page/2707524/
Smoking Pot Eases Tremors in Parkinson’s (news–2013) http://www.medpagetoday.com/MeetingCoverage/MDS/39933
The Truth About Marijuana Smoke: A Smelly Study (news/ad–2013) http://www.airfilters.com/blog/the-truth-about-marijuana-smoke-a-smelly-study/
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014)http://www.cfp.ca/content/60/12/1083.long
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0108282
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24614667
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25135301
Inhaled medicinal cannabis and the immunocompromised patient (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25216851
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25264643
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901929-2/abstract?cc=y
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25533893
Pot Smokers Show Less Inflammation (news – 2014) http://news.yahoo.com/pot-smokers-show-less-inflammation-150518763.html
Marijuana use associated with lower death rates in patients with traumatic brain injuries (news – 2014) http://www.eurekalert.org/pub_releases/2014-10/labr-mua100214.php
Marijuana In A Pill? Why Patients Might Be Better Off Smoking It (news – 2014) http://www.leafscience.com/2014/01/19/marijuana-pill-patients-might-better-smoking/
top
Marijuana may slow spread of HIV (news – 2014) http://www.upi.com/blog/2014/02/19/Marijuana-may-slow-spread-of-HIV/4561392843139/
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25623697
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst-2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
How Medical Marijuana’s Chemicals May Protect Cells (news-2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full-2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25623697
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (abst-2015) http://www.sciencedirect.com/science/article/pii/S0885392414003121
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25716487
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25978795
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26152606
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26187456
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969
Substance abuse risk not greater in those using medical marijuana with prescribed opioids (news-2015) http://www.eurekalert.org/pub_releases/2015-05/joso-sar051115.php
How Medical Marijuana’s Chemicals May Protect Cells (news–2015) http://www.scientificamerican.com/article/how-medical-marijuana-s-chemicals-may-protect-cells/


SOCIAL ADJUSTMENT/BEHAVIOR
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full–2010) http://eurpub.oxfordjournals.org/content/20/2/157.long
top

Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
Cannabis and crime: findings from a longitudinal study (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19839964/full_citation/Cannabis_and_crime:_findings_from_a_longitudinal_study_
A Life-course Perspective on the “Gateway Hypothesis” (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20943588
Gender moderates the impact of stereotype threat on cognitive function in cannabis users (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20483199
Are Stoners Really Dumb, or Do They Just Think They Are? (news-2010) http://healthland.time.com/2010/11/18/are-stoners-really-dumb-or-do-they-just-think-they-are/
Gender differences in adolescent marijuana use and associated psychosocial characteristics (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359836/
Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among Southeast Asian Adolescents and Emerging Adults (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281/?tool=pubmed
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
The social contagion effect of marijuana use among adolescents (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
The association between early conduct problems and early marijuana use in college students (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163297/
Profile of Psychoactive Substances Consumption in Workplace (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21635864
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21733007
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21926420
Oregon’s workplaces safest ever, despite 40,000 medical marijuana patients (news–2011) http://www.examiner.com/article/oregon-s-workplaces-safest-ever-despite-40-000-medical-marijuana-patients
The Kids Are All Right, Even if Their Parents Grow Pot (news–2011) http://www.parentdish.com/2011/07/27/the-kids-are-all-right-even-if-their-parents-grow-pot/
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full-2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
top
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389197/
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22682099
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
‘It’s just a social thing’: Drug use, friendship and borderwork among marginalized young people (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23352335
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22495620
Cannabinoid 2 receptors regulate impulsive behavior (news–2012) http://medicalxpress.com/news/2012-03-cannabinoid-receptors-impulsive-behavior.html
Does Cannabis Boost Creativity? (news-2012) http://www.wakingtimes.com/2012/03/14/does-cannabis-boost-creativity/
Cannabis and Creativity (news–2012) https://www.psychologytoday.com/blog/psychology-masala/201204/cannabis-and-creativity
The Science Behind Cannabis and Creativity (news–2012) http://www.neboagency.com/blog/the-science-behind-cannabis-and-creativity/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Perception of tobacco, cannabis, and alcohol use of others is associated with one’s own use (full–2013) http://www.ascpjournal.org/content/8/1/15
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Higher rates of adolescent substance use in child welfare versus community populations in the United States (link to PDF- 2013) http://www.jsad.com/jsad/article/Higher_Rates_of_Adolescent_Substance_Use_in_Child_Welfare_Versus_Community_/4863.html
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23359015
Illegal drugs and delinquency (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23434380
The role of child protection in cannabis grow-operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23453301
CB1 receptor signaling regulates social anxiety and memory (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23647582
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24261614
top
Can Marijuana Reduce Social Pain? (abst – 2013) http://spp.sagepub.com/content/early/2013/05/13/1948550613488949.abstract
Cannabis Use, Employment, and Income: Fixed-Effects Analysis of Panel Data (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23793384
CB1 cannabinoid receptor-mediated aggressive behavior (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23916480
Cannabis use motives and personality risk factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24368004
This bud’s for you: Marijuana identified as a buffer against loneliness, study suggests (news–2013) http://o.canada.com/life/marijuana-can-act-as-buffer-against-loneliness-study-suggests/
Use of Marijuana, Inhalants Higher in Teens in Child Welfare System: Study (news–2013) http://www.drugfree.org/join-together/drugs/use-of-marijuana-inhalants-higher-in-teens-in-child-welfare-system-study
Marijuana Unlikely To Cause Violence, Study Finds (news–2013) http://www.leafscience.com/2014/01/10/marijuana-unlikely-cause-violence-study-finds/
Marijuana Use In Prisons: Why The Swiss Think It’s Safe And Positive (news–2013) http://www.medicaldaily.com/could-marijuana-use-lead-calmer-prison-environment-swiss-prisons-finddrugs-effects-inmates-positive
The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 (full – 2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125187/
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
Marijuana Policy in Colorado (full – 2014) http://object.cato.org/sites/cato.org/files/pubs/pdf/working-paper-24_2.pdf
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement? (full–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901893-6/fulltext
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A 90-day diary analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858531/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full – 2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25134048
Interpersonal Guilt and Substance Use in College Students. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24579980
Strain and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
top
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25099311
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25454117
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Risk-taking in schizophrenia and controls with and without cannabis dependence (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467541
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25547462
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst-2014)
http://www.ncbi.nlm.nih.gov/pubmed/25024347
Marijuana Smokers Are Moral And Selfless In Romantic Relationships, Survey Suggests (news–2014) http://www.ibtimes.com/marijuana-smokers-are-moral-selfless-romantic-relationships-survey-suggests-1639310
Marijuana Use Results in Less Domestic Violence (news–2014) http://blog.sfgate.com/smellthetruth/2014/08/19/marijuana-in-marriage-equals-less-violence-study-finds/
10 percent of Americans admit to illicit drug use (news–2014) http://www.myfoxmaine.com/story/26450180/10-percent-of-americans-admit-to-illicit-drug-use
After California decriminalized marijuana, teen arrest, overdose and dropout rates fell (news–2014) http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/15/after-california-decriminalized-weedteen-arrest-overdose-and-dropout-rates-fell/
Pot Is the New Normal (news – 2014) http://time.com/3514137/marijuana-legalization-colorado-new-normal/
Harvard Potheads: Then and Now (news – 2014) http://www.thecrimson.com/article/2014/9/12/harvard-potheads-then-andnow/?utm_source=thecrimson&utm_medium=web_primary&utm_campaign=recommend_sidebar
Cato Paper Highlights Marijuana Legalization’s Ho-Hum Impact in Colorado (news – 2014) http://reason.com/blog/2014/10/27/cato-paper-highlights-marijuana-legaliza
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Young adult cannabis users report greater propensity for risk-taking only in nonmonetary domains (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0376871614020006
top
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Role of CB2 receptors in social and aggressive behavior in male mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25921034
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
From substance use to homelessness or vice versa? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25989002
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26115351
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Pediatrician decides: alcohol or marijuana (news – 2015) http://blog.sfgate.com/smellthetruth/2015/03/16/pediatrician-decides-alcohol-or-marijuana/
An open letter to those who wear cannabis clothes (news – 2015) http://www.pickandmixseeds.co.uk/blogs/cannabis-news/17913624-an-open-letter-to-those-who-wearcannabis-clothes
An Open Letter to Those Who Oppose Cannabis Clothes (news – 2015) http://www.ladybud.com/2015/05/19/an-open-letter-to-those-who-oppose-cannabis-clothes/
Getting high in senior year: NYU study examines reasons for smoking pot (news – 2015) http://www.eurekalert.org/pub_releases/2015-06/nyu-ghi062915.php
Retired Cop: I Never Encountered A Person ‘Acting Out Under The Influence Of Marijuana’ (news – 2015) http://www.huffingtonpost.com/2015/05/12/texas-marijuana-ad_n_7261626.html


SPASTICITY
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (abst – 2010) http://msj.sagepub.com/cgi/content/abstract/16/6/707?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabis&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21142261
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst – 2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF – 2011) http://www.dovepress.com/articles.php?article_id=7675
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
top
Cannabinoids in children (abst – 2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
The Therapeutic Potential of Cannabis and Cannabinoids (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full – 2012) http://msj.sagepub.com/content/18/2/219.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/pdf/ISRN.NEUROLOGY2012-802649.pdf
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full – 2012) http://www.cmaj.ca/content/184/10/1143.long
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
What place for cannabis extract in MS? (abst – 2012) http://dtb.bmj.com/content/50/12/141.abstract
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23011861?dopt=Abstract
Smoked Cannabis Reduces Some Symptoms of Multiple Sclerosis (news – 2012) http://health.ucsd.edu/news/releases/Pages/2012-05-14-smoked-cannabis-reduces-symptoms-of-multiple-sclerosis.aspx
Cannabis as Painkiller (news – 2012) http://www.sciencedaily.com/releases/2012/08/120807101232.htm
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full – 2013) http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/22726074
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23625705
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24121462
top
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full – 2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full – 2014) http://www.karger.com/Article/FullText/357742
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosis related spasticity. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25278116
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25467189
“Disease Modifying Nutricals” for multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ane.12287/full
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857324
top
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26103030
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26103031
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26126926
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cannabinoids for the Treatment of Movement Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Huge New Review Shows What Medical Marijuana May (and May Not) Help (news–2015)
https://www.yahoo.com/health/huge-new-review-shows-what-medical-marijuana-may-122209836947.html
Can Medical Marijuana Treat Multiple Sclerosis? (news–2015) http://www.webmd.com/multiple-sclerosis/features/medical-marijuana-multiplesclerosis?src=RSS_PUBLIC


SPINAL CORD INJURY
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/?tool=pubmed
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
top
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst – 2011) http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/lb422?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21265596/abstract/Spinal_Cord_Injuries_Induce_Changes_of_CB1_Cannabinoid_Receptor_and_C_C_Chemokine_Expression_in_Brain_Areas_Underlying_Circuitry_of_Chronic_Pain_Conditions_
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265030/?tool=pubmed
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst – 2012) http://www.biomedexperts.com/Abstract.bme/22791629/A_cell_population_that_strongly_expresses_the_CB1_cannabinoid_receptor_in_the_ependyma_of_the_rat_spinal_cord
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http://www.jneuroinflammation.com/content/10/1/91
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF – 2013) http://www.eurekaselect.com/107976/article
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
top
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Cannabinoids to treat spinal cord injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25805333
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25881484
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231


SPINOCEREBELLAR ATAXIA/SCA
Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145934/
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969


SPLEEN
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182059/
top
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013) http://www.jleukbio.org/content/92/5/1093.full
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full-2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687668/
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23508466
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25497453
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full-2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/


SPORTS
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20872894
High-performance sport, marijuana, and cannabimimetics (full-2011) http://jat.oxfordjournals.org/content/35/9/624.long
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22872465
Broncos Linebacker Failed Two Drug Tests By Providing ‘Non-Human Urine’ (news-2012) http://www.thepostgame.com/blog/dish/201207/broncos-linebacker-failed-two-drug-tests-providing-non-human-urine
Why should Cannabis be Considered Doping in Sports? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Athletes and Pot: Legalized marijuana in a league of its own (news-2013) http://www.denverpost.com/sports/ci_24809768/athletes-and-pot-legalized-marijuana-league-its-own?source=rss
UFC Raises Marijuana Testing Threshold (news–2013) http://www.theweedblog.com/ufc-raises-marijuana-testing-threshold/
Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS (full-2014) http://journal.chemistrycentral.com/content/8/1/73
UPLC-ESI-Q-TOF-MSE identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24742771
Marijuana Bowl: Leading Up To Football’s Biggest Game, The NFL May Want to Consider Legalizing Weed As Way To Treat Concussions (news-2014) http://www.medicaldaily.com/marijuana-bowl-leading-footballs-biggest-game-nfl-may-want-consider-legalizing-weed-way-treat-267570
top
CHART: College Lacrosse Athletes Are More Likely To Use Marijuana Than Any Other Sport (news–2014)http://finance.yahoo.com/news/chart-college-lacrosse-athletes-more-170509114.html;_ylt=AwrTWfyJpdJTKAsAdCjQtDMD
Annual banned-substance review: analytical approaches in human sports drug testing (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/dta.1769/full
Marijuana’s Surprising Effects On Athletic Performance (news–2015) http://finance.yahoo.com/news/marijuanas-surprising-effects-athletic-performance-183230768.html;_ylt=AwrTWVV1Z8BUa1EAyA_QtDMD
Is it time to legalize marijuana in sports? (news–2015) http://www.sandiegouniontribune.com/news/2015/aug/01/marijuana-sports-opioids-arguments-kyle-turley/
Schools employ many different ways to test for drugs (news–2015) http://www.abqjournal.com/625738/sports/schools-employ-many-different-ways-to-test-for-drugs.html


STEM CELLS
Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2975171/?tool=pubmed
Pleiotropic effects of prostaglandin E(2) in hematopoiesis; prostaglandin E(2) and other eicosanoids regulate hematopoietic stem and progenitor cell function (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21722751
Scientists Meet to Discuss Cannabinoids and Stem Cells (news – 2011) http://www.examiner.com/medical-marijuana-in-philadelphia/scientists-meet-to-discuss-cannabinoids-and-stem-cells#ixzz1RmgEd9oq
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22901257
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immunosuppressive Properties (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842278/
The effect cannabichromene on adult neural stem/progenitor cells. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23941747
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system (abst-2013) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23231/abstract
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936357/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. (link to PDF–2014) http://life.scichina.com:8082/sciCe/EN/abstract/abstract513395.shtml#
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
top
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells (full-2015) http://www.hindawi.com/journals/bmri/2015/874982/
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways. (full – 2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25931248
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26114153


STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE
Science/Human: Cannabis effective in a patient with stiff person syndrome (news-2012) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=376
Stiff Person Syndrome (news-2012) (needs registration) http://www.inspire.com/groups/rare-disease/discussion/stiff-person-syndrome-18/
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019963/


STRESS
Endogenous cannabinoid signaling is essential for stress adaptation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez
Motion Sickness, Stress and the Endocannabinoid System (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?tool=pmcentrez
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full – 2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress (full – 2010) http://www.nature.com/npp/journal/v35/n11/full/npp201099a.html
Receptors triggered by pot may lessen hit from chronic stress (news–2010) http://arstechnica.com/science/2010/05/brains-endogenous-cannabinoids-lessen-impact-of-stress/
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full – 2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
top
Endocannabinoids and the cardiovascular response to stress (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21708837
Effects of exercise stress on the endocannabinoid system in humans under field conditions (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22101870
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21600961
New Findings on How the Brain’s Own Marijuana-Like Chemicals Suppress Pain (news – 2011) http://www.alphagalileo.org/ViewItem.aspx?ItemId=113538&CultureCode=en
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652685/
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice (full – 2012) http://eurheartj.oxfordjournals.org/content/33/24/3124.full
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response (abst – 2012) http://www.journaldatabase.org/articles/bidirectional_regulation.html
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22777139
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst – 2012) http://content.karger.com/produktedb/produkte.asp?doi=339113
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/23237313
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress (abst – 2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02355.x/abstract
top
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full – 2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical Cannabis (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Emotional, endocrine and brain anandamide response to social challenge in infant male rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23660109
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23743650
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23954749
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24035186
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24037493
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24141570
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24316201
Amygdala FAAH and anandamide: mediating protection and recovery from stress (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24325918
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24367128
Why resolutions about taking up physical activity are hard to keep (news-2013) http://www.thefreelibrary.com/Why+resolutions+about+taking+up+physical+activity+are+hard+to+keep.-a0313904638
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full-2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
A role for endocannabinoids in acute stress-induced suppression of the hypothalamic pituitary-gonadal axis in male rats (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913894/
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression (full – 2014) http://www.journaltcm.com/modules/Journal/contents/stories/141/16.pdf
top
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full – 2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241884/
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24467609
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12716/abstract
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Endocannabinoids and energy homeostasis: An update (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24752980
Cannabinoids and schizophrenia: therapeutic prospects (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24861565
Stress regulates endocannabinoid-CB1 receptor signaling (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24882055
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst – 2014) http://www.freedomwares.ca/p80cannabinoid-receptor-cb2-prevents-development-heart-failure-murine_model-pressure-overload/
Cannabinoids, endocannabinoids and stress (abst – 2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch5/summary
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25048388
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (abst – 2014) http://www.cell.com/neuron/abstract/S0896-6273%2814%2900017-8
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25111814
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25106694
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25100669
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25221540
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25263804
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25488672
top
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress induced relapse in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25522382
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25548107
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25547713
Marijuana’s anxiety relief effects: Receptors found in emotional hub of brain (news – 2014) http://www.sciencedaily.com/releases/2014/03/140306142803.htm
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full-2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25572435
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25581607
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25618404
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25641667
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst – 2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23539/abstract
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25754825
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25740517
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25707713
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25701682
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/25864425
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
top
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst – 2015)
http://www.ncbi.nlm.nih.gov/pubmed/25958314
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Neurobiological Interactions Between Stress and the Endocannabinoid System (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26068727
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamicpituitary-adrenal axis and other consequences of daily repeated stress (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26092203
Stress-related synaptic plasticity in the hypothalamus (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26087679
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Marijuana Is Effective In Treating Depression – Latest Study (news-2015) http://au.ibtimes.com/marijuana-effective-treating-depression-latest-study-1419071
Research Has Revealed Good News About Marijuana’s Effect on Mental Health (news – 2015) http://www.attn.com/stories/855/marijuana-depression-research-mental-health


STORAGE of CANNABIS
Keep Your Marijuana Fresh With This Long-Term Storage Option (news-2012) http://www.weedist.com/2012/07/keep-your-marijuana-fresh-with-this-long-term-storage-option/
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127


STROKE
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment (full – 2010) http://www.fasebj.org/content/24/3/788.long
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke (link to PDF – 2010) http://www.mdpi.com/1424-8247/3/7/2197
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20875047
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19900555/abstract/The_neuroprotective_effect_of_cannabidiol_in_an_in_vitro_model_of_newborn_hypoxic_ischemic_brain_damage_in_mice_is_mediated_by_CB_2__and_adenosine_receptors_
Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21470162/abstract/Targeting_the_Endocannabinod_System_to_Limit_Myocardial_and_Cerebral_Ischemic_and_Reperfusion_Injury_
top
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21654550
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Medical cannabis: the opportunity versus the temptation (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Update on the role of cannabinoid receptors after ischemic stroke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full-2012) http://stroke.ahajournals.org/content/43/1/211.long
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion (full – 2012) http://www.jneuroinflammation.com/content/9/1/76
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22119394
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia-(abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22678129
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22480617
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23202804
top
“A Marijuana Bud a Day Keeps the Stroke Away” (news-2012) http://www.tokeofthetown.com/2012/04/a_marijuana_bud_a_day_keeps_the_stroke_away.php
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
Is the cardiovascular system a therapeutic target for cannabidiol? (full-2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Drug-Induced Hypothermia in Stroke Models: Does it Always Protect? (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081530/
Does smoking marijuana cause stroke? (article-2013) http://www.thepoisonreview.com/2013/01/26/does-smoking-marijuana-cause-stroke/
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23148948
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23414569
Acupuncture therapy for stroke patients (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24215922
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst-2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.4?sid=eea722c0 -971c-4daa-8b8c-38c0c63c19ad
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23791950
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Synthetic Cannabis and Acute Ischemic Stroke (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24119618
Ischemic stroke after use of the synthetic marijuana “spice” (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24212384
Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24323810
Activation of cortical type 2 cannabinoid receptors ameliorates ischemic brain injury (news-2013) http://www.sciencedaily.com/releases/2013/02/130221141140.htm
Cannabinoid Trans-Caryophyllene Protects Brain Cells From Ischemia (news-2013) http://www.medicalnewstoday.com/articles/256799.php
Smoking “spice” associated with stroke in healthy, young adults (news-2013) http://www.medicalnewstoday.com/releases/269132.php
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF-2014) http://www.mdpi.com/1420-3049/19/11/18781
top
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24721671
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25179201
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25241766
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Cannabinoids in experimental stroke: a systematic review and meta-analysis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25492113
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture
pretreatment via cannabinoid CB1 receptor in mice. (full – 2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Time-Dependent Protection of CB2 Receptor Agonist in Stroke. (full – 2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemiareperfusion through activating cannabinoid receptor 2 (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26032254
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26238742
top


STUTTERING
Marihuana and Stuttering (anecdotal–undated) http://rxmarijuana.com/shared_comments/stuttering.htm
Stuttering, Pain and Battle Fatigue Part 1 (news–2011) http://salem-news.com/articles/february012011/stuttering-pain-pl.php
Stuttering, Pain and Battle Fatigue Part 2 (news–2011) http://salem-news.com/articles/february082011/stuttering-2-plr.php


SUICIDE
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Suicides in other trials led to early termination of trial into effects of weight loss drug rimonabant on cardiovascular outcomes (CRESCENDO study news – 2010) http://www.eurekalert.org/pub_releases/2010-08/l-sio081110.php
Risk of suicide spurs rimonabant trial to end (news-2010) http://www.thefreelibrary.com/Risk+of+suicide+spurs+rimonabant+trial+to+end.-a0238838571
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21497918
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Suicidal ideation and self-harm following K2 use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23304900
Medical Marijuana May Prevent Suicides, Study Finds (news – 2013) http://www.leafscience.com/2014/01/23/medical-marijuana-may-prevent-suicides-study-finds/
Does the legalization of medical marijuana increase completed suicide? (full–2014) http://informahealthcare.com/doi/full/10.3109/00952990.2014.910520
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Medical Marijuana Laws and Suicides by Gender and Age (abst–2014) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612?journalCode=ajph
Cannabis use and suicidal ideations in high-school students (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Medical Marijuana Cuts Suicide Rates By 10% In Years Following Legalization (news–2014) http://www.medicaldaily.com/medical-marijuana-cuts-suicide-rates-10-years-following-legalization-268472
After California decriminalized marijuana, teen arrest, overdose and dropout rates fell (news–2014) http://www.washingtonpost.com/blogs/wonkblog/wp/2014/10/15/after-california-decriminalized-weed-teen-arrest-overdose-and-dropout-rates-fell/
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623
top